Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...

Individuals transitioning from multiple daily injections to the Omnipod 5 system experienced an average HbA1c reduction of ...

1 The Pod has an IP28 rating for up to 7.6 meters (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof. 2 Sherr JL, et al. Diabetes Care (2022). Study in 80 people with type 1 diabetes ...

and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology ...

Individuals with type 1 diabetes (T1D) have demonstrated improvements in glycaemic control after transitioning away from daily insulin injections to Insult’s Omnipod 5 automated insulin delivery ...

1 The Pod has an IP28 rating for up to 7.6 meters (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof. 2 Sherr JL, et al. Diabetes Care (2022). Study in 80 people with type 1 diabetes ...

Question: How is the Omnipod system covered under Medicare now that my doctor and I are considering it to help control my diabetes? Answer: The Omnipod system is an insulin delivery system that allows ...

Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its intention to offer, ...

Insulet Corporation, a global leader in tubeless insulin pump technology with its Omnipod brand of products, shared new Omnipod 5 clinical data from its RADIANT study. Results from this multinational ...